OSTIY yields 5.41% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, OSTIY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OSTIY + JNJ for your $10,000?
Österreichische Post AG, together with its subsidiaries, provides postal and parcel services in Austria, Turkey, Germany, and internationally. It operates in three divisions: Mail, Parcel & Logistics, and Retail & Bank. The Mail division engages in the collection, sorting, and delivery of letters and document shipments, addressed and unaddressed direct mail, and newspapers and magazines, as well as online services, such as e-letter and cross-media solutions; and physical and digital services in customer communications and document processing. The Parcel & Logistics division offers solutions for parcel and express mail items; and value-added services, including food delivery, warehousing, order picking, returns management, and web shop logistics and infrastructure, as well as cash transportation services. The Retail & Bank division is involved in the provision of telecommunication products and merchandise; postal, financial, and payment transaction services; and self-service solutions, such as pick-up and drop-off stations at various locations. It operates a network of 1,757 postal service points, including 395 company-operated postal branches and 1,362 postal partners. The company is headquartered in Vienna, Austria. Oesterreichische Post AG is a subsidiary of Österreichische Beteiligungs AG.
Full OSTIY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.